In total, 679 HIV-positive patients from 4 clinics in Urumqi city were given structured questionnaires by the doctors or nurses treating them. Health-related quality of life (HRQL) was assessed using the Chinese Patient-Reported Outcome Quality of Life-HIV questionnaire versions in Mandarin and Uyghur. This tool has been used in other parts of China and several countries. ), the HRQL was significantly lower among HIV-positive patients in Xinjiang, with regard to the dimension of treatment impact and general health score. The health concern was similar to Brazil and Cambodia but lower than other countries and CS China. Our findings showed high stigmatization: 86% of the patients were afraid to tell others they were HIV positive and 69% often felt or always felt depressed. Only 1% of the patients were on antidepressant treatment.
Introduction
For people living with HIV or AIDS (PLWHA), antiretroviral therapy (ART) has significantly prolonged survival. As HIV infection has evolved into a chronic disease, health care systems had to move from palliative care to comprehensive management. 1 All HIV-positive patients require regular and routine medical checkups and health care.
The HIV-related stigma and discrimination pose a major barrier to HIV prevention and care worldwide. [2] [3] [4] [5] The following issues emerged in various forms in health care settings: refusal of care, suboptimal services, excessive precautions, isolation, mandatory testing, and violation of confidentiality. Negative attitudes have led to humiliation and blaming 4,6,7 of patients. These attitudes and forms of behavior discourage people from seeking HIV testing and counseling and from accessing treatment and care. [8] [9] [10] The increased tolerability of ART, 11 together with reduced pill burden and dosing frequency, has had positive influences on health-related quality of life (HRQL). 12 However, many PLWHA who survived the early era of combination therapy experience residual negative effects from the drugs they took then. These include lipodystrophy, 13 neuropathy, 14 and persistent immunosuppression, 15 which can impair quality of life. In resource-limited settings such as western China, it is still common to use older combinations of antiretroviral drugs, which frequently cause side effects. Social circumstances such as unemployment and inadequate housing 16 and emotional stressors-HIV-related stigma 17 -can also diminish HRQL. 18 A marked feature of HIV-related stigma is that PLWHA are often considered as vectors responsible for the spread of a contagious and fatal infection and are associated with practices marked as deviant by many societies, including drug abuse and sex work. 19 Stigma can also have an internal dimension in the form of the patient's self-condemnation, where one feels deserving of society's disapprobation. 19, 20 This internalized stigma is predictive of inferior outcomes in PLWHA. 21, 22 Several HIV-specific HRQL instruments have been developed, including the Medical Outcomes Study HIV Health Survey (MOS-HIV), 23 the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI), 24 the HIV Overview of Problems-Evaluation System (HOPES), 25 HIV/ AIDS-Targeted Quality of Life (HAT-QOL), 26 the AIDS Time-oriented Health Outcome Study (AIDS-HAQ), 27 and the Multidimensional Quality of Life Questionnaire for Persons with HIV/AIDS (MQOL-HIV). 28 However, many of them were developed before the ART era. 29 Patient-Reported Outcome Quality of Life-HIV (PROQOL-HIV) covers important and previously neglected dimensions in other instruments such as treatment impact (TI) and has been used in international studies in Europe, Oceania, Asia, North America, Latin America, and sub-Saharan Africa. 30 
Aims
The aims of this study were to compare the quality of life among HIV-positive patients in Xinjiang, China, with data available from other countries and the Central-South (CS) region of China.
Methods
A total of 679 HIV-positive patients were recruited from 4 clinics in Urumqi between June 2013 and April 2014. Urumqi city is the capital of Xinjiang Uyghur Autonomous Region in the Northwestern part of China, with 3.46 million inhabitants in 2013.
Study inclusion criteria were as follows: (1) confirmed HIV-positive status, (2) on ART, (3) age 18 years or older, (4) physical and cognitive capability to participate in the study, and (5) patient consent after oral information.
In this consecutive case series, all patients were invited to participate in the survey when they came to the clinics for routine checkups. None refused to participate. All patients were given individual treatment numbers at the clinics, ensuring that they are not included more than once in the study.
The following 3 questionnaires were used for the study: (1) sociodemographic survey, (2) the Patient-Reported Outcome Quality of Life-human immunodeficiency virus (PROQOL-HIV), 30 and (3) HIV symptom index. 31 Clinical characteristics, including CD4 count, the duration of ART, and concomitant infections were obtained from medical records. Details of the antiretroviral medication used were not obtained.
When the patients came to the clinic for regular clinical checkups, the 3 questionnaires were administered, which were self-completed by them during the visit. The doctors and nurses responsible for the treatment were available for clarifications and questions. The Mandarin versions of questionnaires were previously validated in China. The linguistic validation from Mandarin versions into Uyghur language included forward translation, back translation, harmonization, and tests of understanding. The patients were given questionnaire according to their mother tongue. At all the clinics there were doctors or nurses who could speak both the languages.
Questionnaire 1: Sociodemographic Survey
Data were obtained on age, sex, marital status, level of education, and employment. We defined 2 classes for educational level. "Low" meant no studies or primary school level only, while "higher" included secondary school or university.
Questionnaire 2: The PROQOL-HIV
The PROQOL-HIV questionnaire is composed of 43 items. Out of the items 38 are grouped into 8 dimensions as follows: treatment impact (TI, 10), body change (BC, 4), health concerns (HC, 4), emotional distress (ED, 4), stigma (ST, 2), intimate relationships (IR, 3), social relationships (SR, 2), and physical health and symptoms (PHS, 9 items). The treatment impact dimension is comprised of several items related to treatment, including satisfaction with care and adherence to treatment regimen (reverse scored) together with being disturbed by pill scheduling.
Participants rated the extent to which they had experienced each of the 43 items over the past 2 weeks on a 5-point Likerttype scale ranging from 1 ¼ never to 5 ¼always. One item was an exception, where response categories ranged from 1 ¼ very good to 5 ¼ very poor. Summated scale scores are expressed on a 0-to 100-point scale, where higher values reflect a better HRQL. The main properties, including the validity and reliability of the questionnaire and comparisons with other commonly used HRQL instruments, have previously been described by Duracinsky and coworkers. 30 A simplified 0-to 100-point scoring scheme is also available for the PROQOL-HIV questionnaire, with the following 4 dimensions. First, physical health state and symptoms (PHS, 11 items); second, health concerns, body image, and mental distress (COG, 10 items); third, social and intimate relationships (REL, 7 items); and fourth, treatment-related impact (TRT, 10 items).
Questionnaire 3: HIV Symptom Index
The symptom index comprised 32 common and HIV-specific symptoms scored in terms of presence/absence and severity on a 4-point scale (1 ¼ not at all to 4 ¼ quite a bit). 31 
Statistical Methods
A confirmatory factor analysis (CFA) was used to verify the hypothesized 4-domain scaling scheme (PHS, COG, REL, and TRT) of the sample. A multigroup CFA (Multiple Indicator Multiple Cause model) was used to assess the equivalence of factor mean scores across Uyghur and Han patients. Genders, and injecting drug use, were also added as covariates in this multigroup analysis. Standard fit indices were used to assess goodness of fit of CFA models, where it is usually considered that a comparative fit index >0.90 is indicative of adequate model fit, with values near 0.95 being preferable, and a root mean square error of approximation below 0.08 (respectively, 0.06) are indicative of acceptable (respectively good) model fit. 32 Biomedical and demographic data were summarized using descriptive statistics. Two-group comparisons were performed using Wilcoxon (continuous outcome) and Pearson chi-square (categorical outcome) tests. Differences between groups with P values <.05 were regarded as statistically significant.
Ethical Considerations
The study was approved by the ethics committee at the First Affiliated Hospital of Xinjiang Medical University (20090212-01).
Results
Among the 679 patients, 411 (61%) were men. Mean age was 40 years (standard deviation [SD] ¼ 9, range 20-84) for men and 39 years (SD ¼ 8, range 21-61) for women. Fifty-two percent of them were single, divorced, or widowed. Three hundred and fifty-two (53%) had low education level, and 338 (50%) were unemployed. Among the 268 women, 153 (57%) had children or were pregnant. The sociodemographic and biomedical data are summarized in Table 1 . The main route of HIV infection was intravenous drug use (IVDU) in 68% of the cases.
The median CD4 count was 252 cells/mm 3 . No statistically significant difference was seen in CD4 count between ethnic groups, sexes, IVDU, and non-IVDU groups. Many of the patients were slim, and the median body mass index was 20.
Two hundred and twenty-eight (34%) patients had previous or concomitant infections including tuberculosis 88 (13%), pneumocystis pneumonia 65 (10%), herpes simplex infection 53 (7.8%), oral candidiasis 50 (7.4%), bacterial pneumonia 46 (6.8%), and sepsis 5 (0.7%). Data on the proportion of active ongoing infection is not available but is probably low as they were outpatients. Ten patients had Kaposi sarcoma (1.5%). Hepatitis B surface antigen (HBsAg) was found in 144 (21%), and 148 (22%) had hepatitis C antibodies, but no data were available on hepatitis C virus RNA.
There were more single patients in the IVDU group (25%) than in the non-IVDU group (15%; P ¼ .044). Patients with IVDU had higher prevalence of HBsAg (25%) compared to 13% in non-IVDU (P < .001), and 23% had hepatitis C antibodies compared to 20% in non-IVDU (ns). We have no data on liver function or treatment for hepatitis, but treatments for hepatitides B and C were not generally available in Xinjiang.
In Figure 1 , we present the results from the simplified scoring scheme for the PROQOL-HIV questionnaire. They demonstrate low scores on the COG dimension which includes health concerns, body image, and mental distress.
We compared our study from 2013 to 2014 with a study in 2009 from CS China30 reporting that more patients in Xinjiang, Northwestern China, were living alone, had depression and cardiovascular disease, and were IVDUs (see Table 2 ).
The average scores of HRQL for the current sample in Xinjiang (2013-2014) were compared to a 2009 sample of 100 patients from CS China and each of the 7 countries mentioned earlier after the validation study of PROQOL-HIV. 30 As shown in Figure 2 , the patients from Xinjiang had a significantly lower HRQL than patients from France, Australia, United States, Brazil, Thailand, Cambodia, Senegal, and CS China when comparing TI and general health scores. The dimension HC was similar to Brazil and Cambodia and lower than other countries and CS China. With regard to SR, scores were similar to Cambodia and CS China and lower than the other countries. Scores of ED were similar to CS China and Senegal and lower than those of the other countries. Our patients had significantly lower scores with regard to PHS than patients from Australia, France, Senegal, Thailand, and the United States. Scores regarding BC were lower than that of patients from France and United States. Our patients had lower scores on ST than Australia, Cambodia, Thailand, and the United States, although they were higher than Senegal and similar to scores in other countries. We found no significant differences related to sex, ethnic groups, or age. Analysis of responses to individual items of the PROQOL-HIV questionnaire showed that 86% of the patients were afraid to tell others they are HIV positive, 84% patients were worried about the follow-up results, 73% were afraid that their condition might worsen, 55% had fears of infecting others, and 69% reported depression in the questionnaire, but only 1% were on antidepressant treatment according to patients' records, 70% had financial difficulties, and 23% of patients felt their relationships with family or friends were limited. Seventy-three percent reported their religious belief helped them to cope with HIV.
In this study, the 5 most prevalent symptoms reported by the HIV symptom index questionnaire were fat redistribution (31.2%), fatigue (30.0%), nausea (26%), vomiting (24.4%), and fever (22.4%). The highest rated symptoms in terms of discomfort or disturbance were fatigue (0.6 points out of a maximum of 3), headache (0.5), difficulties to fall asleep or insomnia (0.4), fat redistribution (0.4), and fever (0.4). A Spearman rank correlation between the frequency of reports and the average ratings of symptom discomfort was .841 (95% confidence interval: 0.625-0.956). The total number of reported symptoms was negatively correlated to the following 4 simplified HRQL dimensions: PHS (À.351), COG (À.353), REL (À.210), and TRT (À.250), all Ps < .05.
Discussion
This study describes the HRQL among HIV-positive patients on ART, in Xinjiang, Western China, an area with low levels of education and a high proportion of IVDUs, and many of whom live alone. In Xinjiang, more patients had cardiovascular diseases compared to CS China. 30 This is closely related to eating habits, as a typical Xinjiang diet comprise food with high fat content.
The patients had a low median CD4 count of 252 cells/mm 3 , despite being on antiretroviral medication, probably due in many cases to the late start of HIV treatment. In Xinjiang, antiviral treatment was free of cost but not for the other infections, except for tuberculosis. In addition, patients needed to pay for travel expenses and accommodation. It is likely that many of the patients did not receive appropriate care for these concomitant infections.
The multigroup CFA demonstrated the clear negative effect of injecting drug use on all HRQL scores. A study from South China has also shown this. 33 As in other countries, IVDUs often have severe social problems, affecting the quality of life. The IVDUs usually have poor living conditions, financial problems, and lower adherence to medical treatments, all of which can contribute to a vicious circle. The HRQL was low in Xinjiang than in CS China and 7 other countries, 30 especially on the dimensions TI, ED, HCs, and summarized general health score. In Xinjiang, this can be due to more limited resources for health care and support and can also be related to the high proportion of IVDUs in the sample.
The rate of depressive symptoms observed in our sample was 69%, similar to some previous studies 34, 35 but higher than that in CS China. 30 It is remarkable that only 1% of our patients received antidepressive treatment. Adequate assessment and treatment of depression are critical to improving the overall health outcomes in PLWH. 36 Routine screening for depression in this population has been recommended for nearly a decade. 37 A published list of recommended quality indicators to care for depression in PLWH includes targeted depression screening and the use of antidepressants. 38 As many as 86% of the patients were afraid to disclose their HIV status to others and 55% had fears of infecting others. The majority of the patients in our study worried about what family, friends, and neighbors will think of them because of their HIV status. Previous studies have shown that social support is significantly associated with better HRQL scores. 39, 40 The difficulties patients had in disclosing their HIV status probably resulted in low levels of social support. The majority of patients in our study were destitute, which might be another reason for lower levels of HRQL.
We found lower HRQL on the dimension stigma when scores were compared to Australia, Cambodia, Thailand, and the United States. Stigma associated with HIV is reported to be a significant predictor of perceived stress and social isolation. 41 Throughout their lives, HIV stigma continues to be a challenge for PLWH. 42 In 1 study, it was shown that HIV-associated stigma, increased loneliness, decreased cognitive functioning, and reduced levels of energy were significantly associated with depression, 43 and the authors suggested that interventions focused on reducing stigma and isolation could have lasting positive effects on perceived mental and physical health in their population. Many researchers suggest that a comprehensive, tailored, and multilevel approach may be best in dealing with these complex issues. 42, 44, 45 There was a significantly lower HRQL score in the "treatment-impact" dimension of our study compared to the results from studies from CS China and 7 other countries. 30 This may be due to the fact that many patients start the ART late, with concomitant opportunistic infections, which leave residual symptoms. It can also be due to the commonly used first-line treatment, including stavudine (d4T) and zidovudine (ZDV), which has higher levels of side effects than the newer and more expensive combinations tenofovir (TDF) or abacavir (ABC).
Most patients (73%) in this study reported that their spiritual or religious belief strongly supported them in their living with HIV. Most of them believed in Islam. Our findings support those reported from Uganda, which acknowledged that involvement in church activities gave patients a new life. 46, 47 To improve HRQL, interventions are needed that will help patients living with HIV to overcome stress and social isolation barriers. It is important to increase social support, to help patients stop IVDU, and to offer free of cost treatments for hepatitides B and C and other concomitant infections. The population having a better general knowledge of HIV can reduce fears and help provide patients with better support.
In our study, the total number of reported symptoms was negatively correlated with HRQL. Fatigue, headache, and fever were related to lower HRQL. A study from Australia 48 showed the following factors had a negative impact on HRQL: depression, another comorbidity, sexual dysfunction, and frequency of experienced symptoms. In our survey, sexual dysfunction was not reported, probably because in the Chinese culture people do not want to talk about sexual and psychological problems.
Limitations
The studies with which we compared our own, in CS China and other countries, were performed in 2009, 4 or 5 years before our study, which may have had an influence on the results. Some patients with poor education were unable to complete the questionnaires independently, and they needed help from the health care workers, which could have influenced their answers. Another limitation in our study was that we have no data on the quality of life of the general population to compare our findings with. We did not collect HRQL data prior to ART initiation, so we could not compare scores before and after ART initiation, as many other studies have done. There were no data on the type of ART administered, thereby unable to relate a reduced HRQL to the use of certain medication.
We conclude that the patients in Xinjiang had low HRQL compared to those in CS area of China and 7 other countries. The fundamental challenges associated with living with HIV such as stress, stigma, poverty, and depression have a negative impact on HRQL and need to be reduced when managing the patients. This should be done while providing access to highquality medical care, together with psychological and social support.
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